Rituximab-pvvr is not an independent predictor for infusion reactions in a cohort given rituximab-pvvr or rituximab: A single-center retrospective study

J Oncol Pharm Pract. 2022 Jun;28(4):1024-1025. doi: 10.1177/10781552221086222. Epub 2022 Mar 4.

Authors

Katherine Triesel¹, Robert Seabury¹, Christopher Miller¹, Allison Field¹, Andrew Burgdorf¹

Affiliation

¹ Upstate University Hospital, Syracuse, NY, USA.

PMID: 35243927
DOI: 10.1177/10781552221086222

No abstract available

Publication types

Letter

MeSH terms

Cohort Studies
Humans
Infusions, Intravenous
Retrospective Studies
Rituximab* / adverse effects

Substances

Rituximab